‘Quite hopeful’: Abortion pill decision could reshape reproductive health war
Regulators are due to decide Thursday whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone.
Regulators are due to decide Thursday whether to uphold, revise or scrap longstanding restrictions on the abortion drug mifepristone.
The FDA concluded that allowing patients to receive abortion pills through the mail will not increase risks.
The FDA concluded that allowing patients to receive abortion pills through the mail will not increase risks.
The FDA concluded that allowing patients to receive abortion pills through the mail will not increase risks.
Pressure mounts on Biden to approve telemedicine for the use of abortion pills.
Pressure mounts on Biden to approve telemedicine for the use of abortion pills.
Pressure mounts on Biden to approve telemedicine for the use of abortion pills.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.
A total of 14 states and New York City supplied POLITICO contact tracing results showing widespread public reluctance to participate in disease tracking.